Literature DB >> 11447144

Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

G E Wood1, S M Dutro, P A Totten.   

Abstract

Haemophilus ducreyi is a gram-negative obligate human pathogen that causes the genital ulcer disease chancroid. Chancroid lesions are deep necrotic ulcers with an immune cell infiltrate that includes macrophages. Despite the presence of these phagocytic cells, chancroid ulcers can persist for months and live H. ducreyi can be isolated from these lesions. To analyze the interaction of H. ducreyi with macrophages, we investigated the ability of H. ducreyi strain 35000 to adhere to, invade, and survive within U-937 cells, a human macrophage-like cell line. We found that although H. ducreyi strain 35000 adhered efficiently to U-937 cells, few bacteria were internalized, suggesting that H. ducreyi avoids phagocytosis by human macrophages. The few bacteria that were phagocytosed in these experiments were rapidly killed. We also found that H. ducreyi inhibits the phagocytosis of a secondary target (opsonized sheep red blood cells). Antiphagocytic activity was found in logarithmic, stationary-phase, and plate-grown cultures and was associated with whole, live bacteria but not with heat-killed cultures, sonicates, or culture supernatants. Phagocytosis was significantly inhibited after a 15-min exposure to H. ducreyi, and a multiplicity of infection of approximately 1 CFU per macrophage was sufficient to cause a significant reduction in phagocytosis by U-937 cells. Finally, all of nine H. ducreyi strains tested were antiphagocytic, suggesting that this is a common virulence mechanism for this organism. This finding suggests a mechanism by which H. ducreyi avoids killing and clearance by macrophages in chancroid lesions and inguinal lymph nodes.

Entities:  

Mesh:

Year:  2001        PMID: 11447144      PMCID: PMC98558          DOI: 10.1128/IAI.69.8.4726-4733.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Haemophilus ducreyi, a cytotoxin-producing bacterium.

Authors:  M Purvén; T Lagergård
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  An F41-K88-related genetic determinant of bovine septicemic Escherichia coli mediates expression of CS31A fimbriae and adherence to epithelial cells.

Authors:  M J Korth; R A Schneider; S L Moseley
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells.

Authors:  T Lagergård; M Purvén; A Frisk
Journal:  Microb Pathog       Date:  1993-06       Impact factor: 3.738

4.  Experimental human infection with Haemophilus ducreyi.

Authors:  S M Spinola; L M Wild; M A Apicella; A A Gaspari; A A Campagnari
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

5.  Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin.

Authors:  S M Dutro; G E Wood; P A Totten
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Differentiation and dedifferentiation of the human monocytic leukemia cell line, U937.

Authors:  H Hosoya; T Marunouchi
Journal:  Cell Struct Funct       Date:  1992-10       Impact factor: 2.212

7.  Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.

Authors:  A A Campagnari; L M Wild; G E Griffiths; R J Karalus; M A Wirth; S M Spinola
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Role of YadA in resistance of Yersinia enterocolitica to phagocytosis by human polymorphonuclear leukocytes.

Authors:  B China; B T N'Guyen; M de Bruyere; G R Cornelis
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  Identification of a hemolytic activity elaborated by Haemophilus ducreyi.

Authors:  K L Palmer; S Grass; R S Munson
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 10.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

View more
  20 in total

1.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

3.  Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains.

Authors:  Patrick Brest; Frédéric Bétis; Nicolas Cuburu; Eric Selva; Magali Herrant; Alain Servin; Patrick Auberger; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

5.  Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling.

Authors:  Jason R Mock; Merja Vakevainen; Kaiping Deng; Jo L Latimer; Jennifer A Young; Nicolai S C van Oers; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Species-specific interaction of Streptococcus pneumoniae with human complement factor H.

Authors:  Ling Lu; Zhuo Ma; T Sakari Jokiranta; Adeline R Whitney; Frank R DeLeo; Jing-Ren Zhang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Haemophilus ducreyi LspA proteins are tyrosine phosphorylated by macrophage-encoded protein tyrosine kinases.

Authors:  Kaiping Deng; Jason R Mock; Steven Greenberg; Nicolai S C van Oers; Eric J Hansen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.

Authors:  Diane M Janowicz; Kate R Fortney; Barry P Katz; Jo L Latimer; Kaiping Deng; Eric J Hansen; Stanley M Spinola
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers.

Authors:  Tricia L Humphreys; Lang Li; Xiaoman Li; Diane M Janowicz; Kate R Fortney; Qianqian Zhao; Wei Li; Jeanette McClintick; Barry P Katz; David S Wilkes; Howard J Edenberg; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.